Bausch Health Companies Inc. Dividends Payable, Current
Bausch Health Companies Inc. (BHC) had Dividends Payable, Current of $15.08 million as of 2010-09-30, per its 10-Q filed 2011-11-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:DividendsPayableCurrent · last filed 2012-02-29
- 2010-09-30: Dividends Payable, Current $15.08M.
- 2010-06-30: Dividends Payable, Current $15.06M.
- 2010-03-31: Dividends Payable, Current $14.26M.
- 2009-12-31: Dividends Payable, Current $14.25M.
| Period end | Dividends Payable, Current | Dividends Payable, Current as first filed |
|---|---|---|
| 2010-09-30 | $15.08M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $15.06M 10-Q · filed 2011-08-08 | |
| 2010-03-31 | $14.26M 10-Q · filed 2011-05-10 | |
| 2009-12-31 | $14.25M 10-K · filed 2012-02-29 | |
| 2009-09-30 | $14.24M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $59.33M 10-Q · filed 2010-11-05 | $14.24M 10-Q · filed 2010-08-06 |
| 2008-12-31 | $59.33M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |